Rense Buijvoets/LinkedIn
May 26, 2026, 14:23
Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?
Rense Buijvoets, Co-owner and Managing director at Sensu, shared a post on LinkedIn:
”1 in 4 deaths worldwide are caused by thrombosis.
What if blood clots could be targeted directly at their source?
TGD001, TargED’s fusion protein in development, binds to blood clots so it can act where it is needed most. By activating plasmin locally, it helps break down VWF and fibrin, allowing the clot to dissolve and blood flow to return.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough